Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Hebert

Showing results (101-110 of 150) with videos related to

Pageof 15
Sort By:
American Journal of Perinatology|August 10, 2012
Nifedipine pharmacokinetics are influenced by CYP3A5 genotype when used as a preterm labor tocolyticDavid M Haas, Sara K Quinney, Jayanti M Clay, et al.
Transplantation|January 1, 2013
Interpreting tacrolimus concentrations during pregnancy and postpartumMary F Hebert, Songmao Zheng, Karen Hays, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 6, 2014
Maternal-fetal disposition of glyburide in pregnant mice is dependent on gestational ageDiana L Shuster, Linda J Risler, Chao-Kang J Liang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 2009
Clonidine pharmacokinetics in pregnancyM L Buchanan, T R Easterling, D B Carr, et al.
Clinical Pharmacology and Therapeutics|October 18, 2012
Measurement and compartmental modeling of the effect of CYP3A5 gene variation on systemic and intrarenal tacrolimus dispositionS Zheng, Y Tasnif, M F Hebert, et al.
Journal of Clinical Pharmacology|September 21, 2005
Pharmacokinetics of micafungin in healthy volunteers, volunteers with moderate liver disease, and volunteers with renal dysfunctionMary F Hebert, Helen E Smith, Thomas C Marbury, et al.
Transplantation|January 29, 2013
CYP3A5 gene variation influences cyclosporine A metabolite formation and renal cyclosporine dispositionSongmao Zheng, Yasar Tasnif, Mary F Hebert, et al.
Journal of Clinical Pharmacology|February 11, 2010
Atenolol pharmacokinetics and excretion in breast milk during the first 6 to 8 months postpartumSara Eyal, Joong D Kim, Gail D Anderson, et al.
Therapeutic Drug Monitoring|September 26, 2012
Pharmacokinetics of tacrolimus during pregnancySongmao Zheng, Thomas R Easterling, Jason G Umans, et al.
Clinical Pharmacology and Therapeutics|February 22, 2008
Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research studyM F Hebert, T R Easterling, B Kirby, et al.
Pageof 15

Showing results (101-110 of 150) with videos related to

Sort By:
Pageof 15
American Journal of Perinatology|August 10, 2012
Nifedipine pharmacokinetics are influenced by CYP3A5 genotype when used as a preterm labor tocolyticDavid M Haas, Sara K Quinney, Jayanti M Clay, et al.
Transplantation|January 1, 2013
Interpreting tacrolimus concentrations during pregnancy and postpartumMary F Hebert, Songmao Zheng, Karen Hays, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 6, 2014
Maternal-fetal disposition of glyburide in pregnant mice is dependent on gestational ageDiana L Shuster, Linda J Risler, Chao-Kang J Liang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 2009
Clonidine pharmacokinetics in pregnancyM L Buchanan, T R Easterling, D B Carr, et al.
Clinical Pharmacology and Therapeutics|October 18, 2012
Measurement and compartmental modeling of the effect of CYP3A5 gene variation on systemic and intrarenal tacrolimus dispositionS Zheng, Y Tasnif, M F Hebert, et al.
Journal of Clinical Pharmacology|September 21, 2005
Pharmacokinetics of micafungin in healthy volunteers, volunteers with moderate liver disease, and volunteers with renal dysfunctionMary F Hebert, Helen E Smith, Thomas C Marbury, et al.
Transplantation|January 29, 2013
CYP3A5 gene variation influences cyclosporine A metabolite formation and renal cyclosporine dispositionSongmao Zheng, Yasar Tasnif, Mary F Hebert, et al.
Journal of Clinical Pharmacology|February 11, 2010
Atenolol pharmacokinetics and excretion in breast milk during the first 6 to 8 months postpartumSara Eyal, Joong D Kim, Gail D Anderson, et al.
Therapeutic Drug Monitoring|September 26, 2012
Pharmacokinetics of tacrolimus during pregnancySongmao Zheng, Thomas R Easterling, Jason G Umans, et al.
Clinical Pharmacology and Therapeutics|February 22, 2008
Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research studyM F Hebert, T R Easterling, B Kirby, et al.
Pageof 15